BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 4115544)

  • 1. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.
    Remold HG; David RA; David JR
    J Immunol; 1972 Sep; 109(3):578-86. PubMed ID: 4115544
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor has a permissive role in concanavalin A-induced cell death of human hepatoma cells through autophagy.
    Lai YC; Chuang YC; Chang CP; Yeh TM
    Cell Death Dis; 2015 Dec; 6(12):e2008. PubMed ID: 26633714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of three lysosomal enzymes in guinea pig macrophages activated by lymphocyte mediators.
    Remold HG; Mednis A
    Inflammation; 1976 Mar; 1(2):175-88. PubMed ID: 24194427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-induced uptake of [14C]glucosamine, [14C]glucose, and [3H]leucine by macrophages.
    Panagides J; Brockman JA; Barg WF
    Inflammation; 1982 Jun; 6(2):201-5. PubMed ID: 7106972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplified lymphokine production phenomenon confirmed by a macrophage 2-D-[3H]deoxyglucose transport assay.
    McCormack JG; Moore AL; Johnson JE; Philp JR
    Infect Immun; 1981 May; 32(2):707-15. PubMed ID: 7019077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism.
    Abe E; Miyaura C; Tanaka H; Shiina Y; Kuribayashi T; Suda S; Nishii Y; DeLuca HF; Suda T
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5583-7. PubMed ID: 6577445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration inhibition factor and blast transformation in human lymphoid cultures stimulated by different agents.
    Dimitriu A; Dy M; Thomson N; Bona C
    Clin Exp Immunol; 1974 Sep; 18(1):141-8. PubMed ID: 4619594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.
    Remold HG
    J Exp Med; 1973 Nov; 138(5):1065-76. PubMed ID: 4583070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes.
    Rich RR; Pierce CW
    J Exp Med; 1973 Mar; 137(3):649-59. PubMed ID: 4570017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production of migration inhibitory factor (MIF) in rabbit lymphocytes by other than immunological mechanism.
    Pekárek J; Svejcar J; Hríbalová V; Johanovský J
    Folia Microbiol (Praha); 1973; 18(5):393-401. PubMed ID: 4357089
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of substances responsible for lymphokine activity from sensitized mouse spleen cells.
    Sandok PL; Hinsdill RD; Albrecht RM
    Infect Immun; 1974 Jun; 9(6):1045-50. PubMed ID: 4208528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enhancement of macrophage bacteriostasis by products of activated lymphocytes.
    Fowles RE; Fajardo IM; Leibowitch JL; David JR
    J Exp Med; 1973 Oct; 138(4):952-64. PubMed ID: 4200649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a lymphocyte factor which alters macrophage functions.
    Nathan CF; Remold HG; David JR
    J Exp Med; 1973 Feb; 137(2):275-90. PubMed ID: 4119587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells.
    McInnes A; Rennick DM
    J Exp Med; 1988 Feb; 167(2):598-611. PubMed ID: 3258008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal activators in pulmonary immune disease.
    Willoughby WF; Willoughby JB; Gerberick GF
    Clin Rev Allergy; 1985 May; 3(2):197-216. PubMed ID: 2985229
    [No Abstract]   [Full Text] [Related]  

  • 17. Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole.
    Daniels JC; Fajardo I; David JR
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4569-72. PubMed ID: 1105584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocompetent cells in resistance to bacterial infections.
    Campbell PA
    Bacteriol Rev; 1976 Jun; 40(2):284-313. PubMed ID: 786253
    [No Abstract]   [Full Text] [Related]  

  • 19. The biochemistry of lymphocyte-derived mediators of immunological inflammation.
    Houck JC; Hellman KB; Chang CM
    Agents Actions; 1978 Jan; 8(1-2):73-9. PubMed ID: 636958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanisms of macrophage activation. II. Parasite destruction in macrophages activated by supernates from concanavalin A-stimulated lymphocytes.
    Buchmüller Y; Mauel J
    J Exp Med; 1979 Aug; 150(2):359-70. PubMed ID: 458379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.